USA Financial Formulas’s Stride LRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-536
Closed -$77.8K 306
2025
Q2
$77.8K Sell
536
-111
-17% -$16.1K 0.01% 192
2025
Q1
$81.8K Sell
647
-298
-32% -$37.7K 0.01% 186
2024
Q4
$98.2K Sell
945
-5
-0.5% -$476 0.02% 204
2024
Q3
$81K Buy
950
+50
+6% +$3.87K 0.01% 185
2024
Q2
$63.5K Buy
900
+510
+131% +$34K 0.01% 206
2024
Q1
$24.6K Sell
390
-2
-0.5% -$121 ﹤0.01% 264
2023
Q4
$23.3K Buy
+392
New +$21.5K ﹤0.01% 235
2019
Q3
Sell
-5,842
Closed -$199K 242
2019
Q2
$199K Buy
5,842
+441
+8% +$14.2K 0.1% 96
2019
Q1
$184K Buy
+5,401
New +$165K 0.12% 95

Other funds holding LRN

USA Financial Formulas's LRN Position: Q3 2025 in Review

USA Financial Formulas sold out of Stride (LRN) in Q3 2025, closing a stake of 536 shares — an estimated $77.8K sold.

USA Financial Formulas first reported a position in LRN in Q1 2019 and held it in 9 quarters. The position peaked at $199K in Q2 2019. 518 funds tracked by Wall St. Rank hold LRN as of Q3 2025.

  • USA Financial Formulas reported no remaining Stride position as of Q3 2025 after selling out during the quarter.
  • USA Financial Formulas sold 536 Stride shares in Q3 2025, an estimated $77.8K.
  • USA Financial Formulas first reported a position in Stride in Q1 2019 and held it in 9 quarters.
  • USA Financial Formulas's Stride position peaked at $199K in Q2 2019.
  • 518 funds tracked by Wall St. Rank held Stride as of Q3 2025.

Based on USA Financial Formulas's 13F filing for Q3 2025, filed 10 Oct 2025.